Why the study?
Long-term prognosis in viral myocarditis remains suboptimal, and the mechanisms of non-coding RNAs in CVB3-induced viral myocarditis remain incompletely understood.
This review summarizes the mechanisms of non-coding RNAs in CVB3-induced viral myocarditis, highlighting their potential as therapeutic or vaccine targets.
Answers are grounded in this paper and cite their sources.
May guide preclinical target selection in CVB3 myocarditis; leaves open clinical validation of non-coding RNA therapies.
Viral myocarditis (VMC) is a common inflammatory disease of the myocardium that is characterized mainly by inflammatory cell infiltration and cardiomyocyte necrosis. Coxsackievirus B3 (CVB3) is a common cause of VMC, although major progress has been made in the treatment of VMC, the long-term prognosis is still not ideal and further research is needed. Non-coding RNAs (ncRNAs) are RNA molecules without coding functions and include microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), which play extensive regulatory roles in gene expression; however, their mechanisms of action in CVB3-induced VMC remain incompletely understood. Here, we review the currently known roles of various ncRNAs in CVB3-induced VMC models, with a focus on cell death, inflammation and viral replication, with the aim of providing a reference for their therapeutic or vaccine development for the treatment of VMC.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: